UK startup funding in H2 2026
European tech funding raised by UK startups during H2 2026.
H2 2026 is in progress (through 2026-11-21): 309 startups in the UK have closed 315 funding rounds and raised €13B in equity funding so far (excluding debt and grants). Debt rounds added €7.9B. Software is the most active sector, and Innovate UK is the most active investor. Data as of 20 Nov 2026.
H2 2026 is in progress — these figures cover rounds through today and will grow as the period completes, so they are not compared to H2 2025.
Equity funding
€13B
excl. debt & grants · +€7.9B debt
Funding rounds
315
Companies
309
Top sector
Software
Rank in Europe
#1
45.7% of European funding
Debt financing
€7.9B
38.7% of total
Top-10 round share
67.9%
of disclosed capital
Rounds ≥ €100M
28
Funding by month
€ raised vs rounds, by monthUK — funding by month, H2 2026 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jul | €3.3B | 73 |
| Aug | €1.4B | 52 |
| Sep | €7.2B | 66 |
| Oct | €2.5B | 74 |
| Nov | €6.2B | 50 |
Top sectors
by € raisedUK — top sectors by capital, H2 2026 — interactive chart.
Data table
| UK — top sectors by capital, H2 2026 | |
|---|---|
| Cloud | €6.3B |
| Healthtech | €5.8B |
| Fintech | €2.6B |
| AI | €1.5B |
| Defence | €1.1B |
| Robotics | €775M |
| Cleantech | €473M |
| Semiconductors | €456M |
Stage mix
by € raisedUK — stage mix, H2 2026 — interactive chart.
Data table
| UK — stage mix, H2 2026 | |
|---|---|
| Debt | €7.9B |
| Series C | €6.1B |
| Other | €2.2B |
| Series B | €1.8B |
| Series A | €1.5B |
| Seed | €445M |
| Growth/Late | €429M |
| Pre-Seed | €76M |
| Grant | €32M |
| Series D+ | €22M |
Exits & M&A
21 Acquisition21 exits.
Top deals
largest disclosed rounds in H2 2026| Company | Stage | Date | Amount |
|---|---|---|---|
| Isomorphic Labs | Series C | Nov 2026 | €4.6B |
| Nscale | Debt | Sep 2026 | €3.0B |
| Nscale | Debt | Sep 2026 | €2.6B |
| Nscale | Debt | Jul 2026 | €787M |
| Fractile | Series C | Oct 2026 | €692M |
| UFORCE | Series A | Nov 2026 | €632M |
| Lendable | Debt | Jul 2026 | €587M |
| CuspAI | Series B | Jul 2026 | €394M |
| FNZ | Other | Sep 2026 | €389M |
| CMR Surgical | Growth/Late | Oct 2026 | €355M |
| Open Cosmos | Other | Sep 2026 | €300M |
| iwoca | Debt | Jul 2026 | €292M |
| OMass Therapeutics | Series C | Oct 2026 | €273M |
| Olix | Series B | Aug 2026 | €270M |
| Volta | Other | Aug 2026 | €260M |
Top investors
most active in H2 2026, by deal count- Innovate UK19 deals
- PXN Ventures10 deals
- British Business Bank9 deals
- Ada Ventures8 deals
- SFC Capital8 deals
- Haatch8 deals
- Oxford Science Enterprises7 deals
- Y Combinator6 deals
- Foresight Group6 deals
- NPIF II – PXN Equity Finance6 deals